WallStreetZenWallStreetZen

NASDAQ: ARTL
Artelo Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ARTL earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$9.6M
Current Profit Margin
0%

ARTL Return on Equity

Current Company
-56.3%
Current Industry
15.6%
Current Market
-9.5%
ARTL's Return on Equity (-56.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ARTL announces earnings.

ARTL Return on Assets

Current Company
-53.6%
Current Industry
2.2%
ARTL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ARTL Return on Capital Employed

Current Company
-65.54%
Current Industry
17.7%
ARTL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARTL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ARTL$0.00-$9.51M-$9.56MN/AN/A
TTNP$306.00k-$5.97M-$6.17M-43.76%N/A
WINT$0.00-$25.64M-$24.83M-100.00%N/A
BWV$0.00-$17.79M-$18.28MN/AN/A
XRTX$0.00-$5.58M-$5.63MN/AN/A
View Top Biotech Stocks

Artelo Biosciences Earnings & Revenue FAQ

What were ARTL's earnings last quarter?

On Invalid Date, Artelo Biosciences (NASDAQ: ARTL) reported Q3 2023 earnings per share (EPS) of -$0.83, up 1.22% year over year. Total Artelo Biosciences earnings for the quarter were -$2.45 million. In the same quarter last year, Artelo Biosciences's earnings per share (EPS) was -$0.82.

If you're new to stock investing, here's how to buy Artelo Biosciences stock.

What was ARTL's earnings growth in the past year?

As of Q4 2023, Artelo Biosciences's earnings has grown year over year. Artelo Biosciences's earnings in the past year totalled -$9.56 million.

What was ARTL's revenue last quarter?

On Invalid Date, Artelo Biosciences (NASDAQ: ARTL) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Artelo Biosciences's revenue was $0.00.

What was ARTL's revenue growth in the past year?

As of Q4 2023, Artelo Biosciences's revenue has grown null year over year. Artelo Biosciences's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.